Cefoperazone/Sulbactam In The Treatment Of Serious Intra-Abdominal And Hepatobiliary Infections.
Cefoperazone/Sulbactam In The Treatment Of Serious Intra-Abdominal And Hepatobiliary Infections.
The primary objective is to collect data on treatment outcomes (clinical and microbiological
 cure), safety and tolerability of treatment with cefoperazone/sulbactam in patients with
 serious intra-abdominal and hepatobiliary infections in Slovakia.
Inclusion Criteria:

 -  Male or female patient of age 18 years or older.

 -  Patient with intraabdominal/hepatobiliary infection.?

 Exclusion Criteria:

 -  Patients with known hypersensitivity to penicillins, cephalosporins, cefoperazone or
 to sulbactam.